NOTICE

This service is temporarily unavailable. The details outlined on this page remain for informational purposes only at this time. 

Food for Thought is proud to introduce the Thermal Breast Scan in the fight against breast cancer. The Thermal Breast Scan is new technology and aids in early breast cancer detection. Unlike mammography, the Thermal system does not expose you to radiation and involves no breast compression. It is also suitable for younger women (age 18-39), pregnant women, those with implants or dense breasts, post-partial mastectomy/lumpectomy and those with a history of concerning mammograms or biopsies.

Recent studies examining the cancer detection performance of “mammography alone”, especially in high risk women (e.g. family history, genetic tendencies, dense breast tissue, etc) have been extremely disappointing. Adding an FDA approved adjunct, the Thermal infrared “physiologic breast imaging” technology to the clinical exam and mammography is the approach we are recommending for virtually all women. It makes sense that this “multimodality approach” (clinical examination + infrared + mammography) would be the best approach for early detection of breast cancer.

In 2014, the Swiss Medical Board conducted a review of the practice of using mammography for screening purposes. The following was reported in The New England Journal of Medicine (23 April 2014 “Abolishing Mammography Screening Programs? A view from the Swiss Medical Board”):

It acknowledged that systematic mammography screening might prevent about one death attributed to breast cancer for every 1000 women screened, even though there was no evidence to suggest that overall mortality was affected. At the same time, it emphasized the harm — in particular, false positive test results and the risk of over-diagnosis. For every breast-cancer death prevented in U.S. women over a 10-year course of annual screening from age 50:

· 490 to 670 women are likely to have a false positive mammogram with repeat examination;

· 70 to 100 an unnecessary biopsy;

· 3 to 14 an over-diagnosed breast cancer that would never have become clinically apparent.

As a result of this review, the Board recommended that no new systematic mammography programs be introduced and that a time limit be placed on existing programs. In addition, it stipulated that the quality of all forms of mammography screening should be evaluated and that clear and balanced information should be provided to women regarding the benefits and harms of screening.